Dr George C Prendergast obtained his PhD degree in 1989 from Princeton University and performed postdoctoral research at the Howard Hughes Medical Institute at New York University Medical Center (1989–1991). He subsequently worked as a staff scientist at Merck Research Laboratories in West Point PA (1991–1993) and in 1994, was appointed as an assistant professor at The Wistar Institute, where he is currently an Associate Professor and Assistant Chair of the Tumor Biology Group. Included among his work on mechanisms of malignant cell transformation and apoptosis are major contributions in the area of Myc protein function, including the definition of its physiological DNA recognition specificity, the cloning and functional analysis of the mouse homolog of Max, and the discovery of Bin1, a Myc box-binding adaptor protein with tumor suppressor roles.

figure 1